$IX Biopharma (42C.SG)$ NEWS RELEASE Breakthrough Sublingual Wafers Raise NAD+ Levels by 76% and Enhance Well-Being in Human Trial SL-NAD+ wafers demonstrated in human trial to: significantly increase blood NAD+ levels by 59% over two weeks and 76% over six weeks compared to baseline improve energy levels, mood, sleep quality, mental clarity, and physical strength be safe and well tolerated
1
Report
hh488
:
They trying to release some positive news prior to the payment of the rights. So don't get caught & jump in right away!
RevelationX
OP
Fundamentalist
:
For me I just exercise my rights based on shares and pay according to estimated amount and see where it goes since already at a loss, no harm seeing how it goes. But do your own DD ba.
$IX Biopharma (42C.SG)$ Can't perform due to lousy management? Can't turn the company around with profitability for so many years.... I have given up on this counter...
2
Report
Fundamentalist
:
Leadership and Management issue usually. Check the individual profiles of the management.
Good morning mooers! Here are things you need to know about today's Singapore: ●Singapore shares opened lower on Tuesday; STI down 0.33% ●Singtel readies US$300m sale of cyber security arm Trustwave, sources say ●Stocks & REITs to watch: iX Biopharma, UHReit, Singtel ●Latest share buy back transactions -moomoo News SG Market Trend Singapore shares opened lower on Tuesday. The$FTSE Singapore Straits Time Index (.STI.SG)$decreased...
$IX Biopharma (42C.SG)$IX Biopharma (SGX:42C) is looking to raise SG$2.7 million ($1.9 million) via the issuance of 13,710,000 shares at SG$0.20 each to C2C Biopharma Holdings, an investment vehicle of investor Lundy Nath.
Flabulousity
:
you should have received an email that asks for your option. I’m new to this an mulling over whether to subscribe at $0.20 when NXYR is now only worth $0.031
In for the long run
OP
:
thanks! In the end I bought with another broker due to the rights subscription. This counter has good prospect so think I will over subscribe too
102404982
:
How does this work? What happens if we go with option 1, to exercise the rights? I understand that we will need to pay a subscription fee of 0.20 per right. Will the rights be converted to shares after you have exercised them? Thanks in advance for the advice!
Singapore's high dividend stocks offer a compelling investment opportunity for those seeking to generate regular income while participating in the potential growth of some of the region's most stable companies. By understanding the benefits and challenges associated with these stocks and conducting thorough research before investing, individuals can effectively incorporate high dividend stocks into their investment strategy. Always consider consulting with financial advisors to tailor investments to your personal financial goals and risk tolerance. With the right approach, high dividend stocks can be a valuable addition to a well-rounded investment portfolio. Singapore's high dividend stocks offer a compelling investment opportunity for those seeking to generate regular income while participating in the potential growth of some of the region's most stable companies. By understanding the benefits and challenges associated with these stocks and conducting thorough research before investing, individuals can effectively incorporate high dividend stocks into their investment strategy. Always consider consulting with financial advisors to tailor investments to your personal financial goals and risk tolerance. With the right approach, high dividend stocks can be a valuable addition to a well-rounded investment portfolio.
hh488 : They trying to release some positive news prior to the payment of the rights. So don't get caught & jump in right away!